Nuclear fluorescence serum reactivity on monkey oesophagus: A new antibody for the follow-up of coeliac disease?

Clinical and Experimental Immunology

Volumn 161, Issue 3, 2010, Pages 417-425

  Picarelli, A ^a,b   Sabbatella, L ^a   Di Tola, M ^a   Silano, M ^c   Nicolussi, A ^b   D'Inzeo, S ^b   Coppa, A ^b  

^a Department of Clinical Sciences   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Anti endomysium; Coeliac disease; Follow up; Gluten free diet; Nuclear fluorescence reactivity

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; ENDOMYSIUM ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN A1; NUCLEAR FLUORESCENCE REACTIVITY RELATED TO CELIAC DISEASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DUODENUM; ESOPHAGUS; FEMALE; FLUORESCENCE; FOLLOW UP; GLUTEN FREE DIET; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; SERUM;

ADOLESCENT; ADULT; ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CACO-2 CELLS; CELIAC DISEASE; ESOPHAGUS; FEMALE; FLUORESCENCE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOLLOW-UP STUDIES; HAPLORHINI; HUMANS; IMMUNOGLOBULIN A; INTESTINE, SMALL; MALE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; SERUM; YOUNG ADULT;

EID: 77955728265     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04184.x     Document Type: Article

References (35)

1. Di Sabatino A, Corazza GR. Celiac disease. Lancet 2009 373 : 1480 1493.
2. Ellis HJ, Ciclitira PJ. Should celiac sufferers be allowed their oats? Eur J Gastroenterol Hepatol 2008 20 : 492 493.
3. Accomando S, Cataldo F. The global village of celiac disease. Dig Liver Dis 2004 36 : 492 498.
4. Heap GA, van Heel DA. Genetics and pathogenesis of celiac disease. Semin Immunol 2009 21 : 346 354.
5. Jabri B, Kasarda DD, Green PH. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol Rev 2005 206 : 219 231.
6. Kagnoff MF. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest 2007 117 : 41 9.
7. Jabri B, Sollid LM. Tissue-mediated control of immunopathology in celiac disease. Nat Rev Immunol 2009 9 : 858 870.
8. Savilahti E, Viander M, Perkkiö M, Vainio E, Kalimo K, Reunala T. IgA antigliadin antibodies: a marker of mucosal damage in childhood celiac disease. Lancet 1983 1 : 320 322.
9. Aleanzi M, Demonte AM, Esper C, Garcilazo S, Waggener M. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001 47 : 2023 2028.
10. Chorzelski TP, Sulej J, Tchorzewska H, Jablonska S, Beutner EH, Kumar V. IgA class endomysium antibodies in dermatitis herpetiformis and celiac disease. Ann NY Acad Sci 1983 420 : 325 334.
11. Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997 3 : 797 801.
12. Uhlig HH, Lichtenfeld J, Osman AA, Richter T, Mothes T. Evidence for existence of celiac disease autoantigens apart from tissue transglutaminase. Eur J Gastroenterol Hepatol 2000 12 : 1017 1020.
13. Stulik J, Hernychova L, Porkertova S et al. Identification of new celiac disease autoantigens using proteomic analysis. Proteomics 2003 3 : 951 956.
14. Shaoul R, Lerner A. Associated autoantibodies in celiac disease. Autoimmun Rev 2007 6 : 559 565.
15. Alaedini A, Green PH. Autoantibodies in celiac disease. Autoimmunity 2008 41 : 19 26.
16. Rostom A, Dubé C, Cranney A et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005 128 : S38 46.
17. Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose celiac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther 2006 24 : 47 54.
18. Dickson BC, Streutker CJ, Chetty R. Celiac disease: an update for pathologists. J Clin Pathol 2006 59 : 1008 1016.
19. Kurppa K, Collin P, Viljamaa M et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009 136 : 816 823.
20. Leffler DA, Edwards George JB, Dennis M, Cook EF, Schuppan D, Kelly CP. A prospective comparative study of five measures of gluten-free diet adherence in adults with celiac disease. Aliment Pharmacol Ther 2007 26 : 1227 1235.
21. Setty M, Hormaza L, Guandalini S. Celiac disease: risk assessment, diagnosis, and monitoring. Mol Diagn Ther 2008 12 : 289 298.
22. Dipper CR, Maitra S, Thomas R et al. Anti-tissue transglutaminase antibodies in the follow-up of adult celiac disease. Aliment Pharmacol Ther 2009 30 : 236 244.
23. Picarelli A, Maiuri L, Frate A, Greco M, Auricchio S, Londei M. Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with celiac disease. Lancet 1996 348 : 1065 1067.
24. Sblattero D, Florian F, Not T et al. The gut as site of production of autoimmune antibodies. J Pediatr Gastroenterol Nutr 2004 39 : S730 1.
25. Stenman SM, Lindfors K, Korponay-Szabo IR et al. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits. BMC Immunol 2008 9 : 6.
26. Carroccio A, Di Prima L, Pirrone G et al. Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis. Clin Chem 2006 52 : 1175 1180.
27. Bonamico M, Sabbatella L, Di Tola M et al. Antiendomysial antibody detection in biopsy culture allows avoidance of gluten challenge in celiac children. J Pediatr Gastroenterol Nutr 2005 40 : 165 169.
28. Troncone R, Caputo N, Micillo M, Maiuri L, Poggi V. Immunologic and intestinal permeability tests as predictors of relapse during gluten challenge in childhood celiac disease. Scand J Gastroenterol 1994 29 : 144 147.
29. Liu E, Li M, Emery L et al. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr 2007 45 : 293 300.
30. Troncone R, Mayer M, Spagnuolo F, Maiuri L, Greco L. Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease. J Pediatr Gastroenterol Nutr 1995 21 : 69 72.
31. Natter S, Granditsch G, Reichel GL et al. IgA cross-reactivity between a nuclear autoantigen and wheat proteins suggests molecular mimicry as a possible pathomechanism in celiac disease. Eur J Immunol 2001 31 : 918 928.
32. Sabbatella L, Di Tola M, Di Cello T et al. Nuclear fluorescence reactivity: a novel sensitive marker in the fine follow-up of celiac disease. Dig Liver Dis 2001 33 : A66.
33. Storch WB, Schloeder U. A new autoantibody in celiac disease. Clin Lab 2002 48 : 19 23.
34. Fasano A, Araya M, Bhatnagar S et al. Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition consensus report on celiac disease. J Pediatr Gastroenterol Nutr 2008 47 : 214 219.
35. Marin GG, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol 2009 15 : 325 329.